Skip to main navigation
Skip to main content
Email Alerts
News
Lilly.com
Menu
Menu
Close
Close
Stock Info
Expand mega menu
Expand submenu
Left
Back
Stock Info
Stock Quote & Chart
Historic Price Lookup
Investment Calculator
Dividends & Stock Splits
Webcasts & Presentations
Financials
Expand mega menu
Expand submenu
Left
Back
Financials
SEC Filings
Annual Reports
Quarterly Results
Key Ratios
Interactive Financials
Debt Securities
Individual Investors
Resources
Expand mega menu
Expand submenu
Left
Back
Resources
Clinical Development Pipeline
Current Medicines
Executive Committee
Key Facts
2023 Year in Review
ESG Report
Search
Email Alerts
News
Lilly.com
Close
Search Lilly.com For Content...
Submit search (disabled)
Search
News
Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase 3 Data
News
Eli Lilly and Company Announces Expansion of Indianapolis R&D Headquarters
News
Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Announce Winners of the My Diabetes Pit Crew Sweepstakes
News
Results of Two Pivotal Baricitinib Trials to be Presented at 2015 American College of Rheumatology Annual Meeting
News
Lilly to Participate in Credit Suisse 2015 Healthcare Conference
News
Lilly and United Way Celebrate Deepening Partnership, Community Impact
News
EMPA-REG OUTCOME®: Top-line renal data to be presented during American Society of Nephrology (ASN) Kidney Week 2015
News
Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis
News
Lilly and Incyte Announce Patients Treated with Baricitinib Demonstrated Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis Compared with Methotrexate
News
Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis
Pagination
Page 1
Next page
››